Plain-English translation of NCT07324798 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing adaptive radiotherapy — a newer way to deliver radiation therapy using real-time MRI imaging to precisely target cancer while reducing damage to healthy tissue. The study focuses on patients with prostate cancer that has returned after surgery or patients with bladder cancer who are being treated without surgery. Researchers want to see if this advanced technique reduces side effects while maintaining or improving how well the treatment works.
Standard radiation therapy can sometimes damage healthy tissue nearby, which may cause side effects. This trial exists to see whether the new treatment, which adjusts the radiation plan based on real-time imaging during each session, can be safer and more effective than traditional approaches.
You likely qualify if…
You likely don't qualify if…
You will receive adaptive radiation therapy delivered by a special machine that combines MRI imaging with radiation. During your treatment, you'll visit the clinic once every two weeks while receiving radiation, and then every three months after treatment ends for follow-up appointments. You'll also be asked to fill out questionnaires regularly about your quality of life and any side effects you experience.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China